Adult Vaccines Market Report

Global Adult Vaccines Market Study Report 2022 Historical Trends, Growth, and Forecast to 2028

  • POSTDATE：Mar 08, 2022
  • PAGES：159
  • REPORT CODE：GMM801391
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Adult Vaccines market report explains the definition, types, applications, major countries, and major players of the Adult Vaccines market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.

    The report contains qualitative and quantitative analysis of the entire industry.

    The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.

    By Player:

    • Novartis

    • Pfizer

    • Protein Sciences

    • Sanofi Pasteur

    • Merck

    • GlaxoSmithKline

    • BioCSL (Seqirus)

    By Type:

    • Influenza

    • Cervical Cancer

    • Zoster Shingles

    • Pneumococcal

    • Meningococcal

    • MMRV

    • Hepatitis

    • DTP

    • Travel and Miscellaneous

    By End-User:

    • Medical Care

    • Healthy

    • Hospita

    By Region:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • Spain

    • France

    • Italy

    • Denmark

    • Finland

    • Norway

    • Sweden

    • Poland

    • Russia

    • Turkey

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Pakistan

    • Bangladesh

    • Indonesia

    • Thailand

    • Singapore

    • Malaysia

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Colombia

    • Chile

    • Argentina

    • Venezuela

    • Peru

    • Puerto Rico

    • Ecuador

    • Others

    GCC

    • Bahrain

    • Kuwait

    • Oman

    • Qatar

    • Saudi Arabia

    • United Arab Emirates

    Africa

    • Nigeria

    • South Africa

    • Egypt

    • Algeriat

    • Others

    Oceania

    • Australia

    • New Zealand

  • TABLE OF CONTENT

    1. Global Adult Vaccines Executive Summary

    • 1.1 Introduction

    • 1.2 Market Panorama, 2022

    2 Coronavirus Impact

    • 2.1 Adult Vaccines Outlook to 2028- Original Forecasts

    • 2.2 Adult Vaccines Outlook to 2028- COVID-19 Affected Forecasts

    • 2.3 Impact on Industry

    3 Strategic Analytics to Boost Productivity and Profitability

    • 3.1 Potential Market Drivers and Opportunities

    • 3.2 New Challenges and Strategies

    • 3.3 Short Term and Long Term Adult Vaccines Market Trends

    4 Key Inferences

    5 Market Overview

    • 5.1 Current Market Scenario

    • 5.2 Porter's Five Forces Analysis

      • 5.2.1 Bargaining Power of Suppliers

      • 5.2.2 Bargaining Power of Consumers

      • 5.2.3 Threat of New Entrants

      • 5.2.4 Threat of Substitute Product and Services

      • 5.2.5 Competitive Rivalry within the Industry

    6 Global Adult Vaccines Market- Recent Developments

    • 6.1 Adult Vaccines Market News and Developments

    • 6.2 Adult Vaccines Market Deals Landscape

    7 Adult Vaccines Raw Materials and Cost Structure Analysis

    • 7.1 Adult Vaccines Key Raw Materials

    • 7.2 Adult Vaccines Price Trend of Key Raw Materials

    • 7.3 Adult Vaccines Key Suppliers of Raw Materials

    • 7.4 Adult Vaccines Market Concentration Rate of Raw Materials

    • 7.5 Adult Vaccines Cost Structure Analysis

      • 7.5.1 Adult Vaccines Raw Materials Analysis

      • 7.5.2 Adult Vaccines Labor Cost Analysis

      • 7.5.3 Adult Vaccines Manufacturing Expenses Analysis

    8 Global Adult Vaccines Import and Export Analysis (Top 10 Countries)

    • 8.1 Global Adult Vaccines Import by Region (Top 10 Countries) (2017-2028)

    • 8.2 Global Adult Vaccines Export by Region (Top 10 Countries) (2017-2028)

    9 Global Adult Vaccines Market Outlook by Types and Applications to 2022

    • 9.1 Global Adult Vaccines Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Influenza Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Cervical Cancer Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Zoster Shingles Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Pneumococcal Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global Meningococcal Consumption and Growth Rate (2017-2022)

      • 9.1.6 Global MMRV Consumption and Growth Rate (2017-2022)

      • 9.1.7 Global Hepatitis Consumption and Growth Rate (2017-2022)

      • 9.1.8 Global DTP Consumption and Growth Rate (2017-2022)

      • 9.1.9 Global Travel and Miscellaneous Consumption and Growth Rate (2017-2022)

    • 9.2 Global Adult Vaccines Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Medical Care Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Healthy Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Hospita Consumption and Growth Rate (2017-2022)

    10 Region and Country-wise Adult Vaccines Market Analysis and Outlook till 2022

    • 10.1 Global Adult Vaccines Consumption (2017-2022)

    • 10.2 North America Consumption Analysis

      • 10.2.1 United States Adult Vaccines Consumption (2017-2022)

      • 10.2.2 Canada Adult Vaccines Consumption (2017-2022)

      • 10.2.3 Mexico Adult Vaccines Consumption (2017-2022)

    • 10.3 Europe Consumption Analysis

      • 10.3.1 Germany Adult Vaccines Consumption (2017-2022)

      • 10.3.2 UK Adult Vaccines Consumption (2017-2022)

      • 10.3.3 Spain Adult Vaccines Consumption (2017-2022)

      • 10.3.4 Belgium Adult Vaccines Consumption (2017-2022)

      • 10.3.5 France Adult Vaccines Consumption (2017-2022)

      • 10.3.6 Italy Adult Vaccines Consumption (2017-2022)

      • 10.3.7 Denmark Adult Vaccines Consumption (2017-2022)

      • 10.3.8 Finland Adult Vaccines Consumption (2017-2022)

      • 10.3.9 Norway Adult Vaccines Consumption (2017-2022)

      • 10.3.10 Sweden Adult Vaccines Consumption (2017-2022)

      • 10.3.11 Poland Adult Vaccines Consumption (2017-2022)

      • 10.3.12 Russia Adult Vaccines Consumption (2017-2022)

      • 10.3.13 Turkey Adult Vaccines Consumption (2017-2022)

    • 10.4 APAC Consumption Analysis

      • 10.4.1 China Adult Vaccines Consumption (2017-2022)

      • 10.4.2 Japan Adult Vaccines Consumption (2017-2022)

      • 10.4.3 India Adult Vaccines Consumption (2017-2022)

      • 10.4.4 South Korea Adult Vaccines Consumption (2017-2022)

      • 10.4.5 Pakistan Adult Vaccines Consumption (2017-2022)

      • 10.4.6 Bangladesh Adult Vaccines Consumption (2017-2022)

      • 10.4.7 Indonesia Adult Vaccines Consumption (2017-2022)

      • 10.4.8 Thailand Adult Vaccines Consumption (2017-2022)

      • 10.4.9 Singapore Adult Vaccines Consumption (2017-2022)

      • 10.4.10 Malaysia Adult Vaccines Consumption (2017-2022)

      • 10.4.11 Philippines Adult Vaccines Consumption (2017-2022)

      • 10.4.12 Vietnam Adult Vaccines Consumption (2017-2022)

    • 10.5 South America Consumption Analysis

      • 10.5.1 Brazil Adult Vaccines Consumption (2017-2022)

      • 10.5.2 Colombia Adult Vaccines Consumption (2017-2022)

      • 10.5.3 Chile Adult Vaccines Consumption (2017-2022)

      • 10.5.4 Argentina Adult Vaccines Consumption (2017-2022)

      • 10.5.5 Venezuela Adult Vaccines Consumption (2017-2022)

      • 10.5.6 Peru Adult Vaccines Consumption (2017-2022)

      • 10.5.7 Puerto Rico Adult Vaccines Consumption (2017-2022)

      • 10.5.8 Ecuador Adult Vaccines Consumption (2017-2022)

    • 10.6 GCC Consumption Analysis

      • 10.6.1 Bahrain Adult Vaccines Consumption (2017-2022)

      • 10.6.2 Kuwait Adult Vaccines Consumption (2017-2022)

      • 10.6.3 Oman Adult Vaccines Consumption (2017-2022)

      • 10.6.4 Qatar Adult Vaccines Consumption (2017-2022)

      • 10.6.5 Saudi Arabia Adult Vaccines Consumption (2017-2022)

      • 10.6.6 United Arab Emirates Adult Vaccines Consumption (2017-2022)

    • 10.7 Africa Consumption Analysis

      • 10.7.1 Nigeria Adult Vaccines Consumption (2017-2022)

      • 10.7.2 South Africa Adult Vaccines Consumption (2017-2022)

      • 10.7.3 Egypt Adult Vaccines Consumption (2017-2022)

      • 10.7.4 Algeria Adult Vaccines Consumption (2017-2022)

    • 10.8 Oceania Consumption Analysis

      • 10.8.1 Australia Adult Vaccines Consumption (2017-2022)

      • 10.8.2 New Zealand Adult Vaccines Consumption (2017-2022)

    11 Global Adult Vaccines Competitive Analysis

    • 11.1 Novartis

      • 11.1.1 Novartis Company Details

      • 11.1.2 Novartis Adult Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 11.1.3 Novartis Adult Vaccines Main Business and Markets Served

      • 11.1.4 Novartis Adult Vaccines Product Portfolio

      • 11.1.5 Recent Research and Development Strategies

    • 11.2 Pfizer

      • 11.2.1 Pfizer Company Details

      • 11.2.2 Pfizer Adult Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 11.2.3 Pfizer Adult Vaccines Main Business and Markets Served

      • 11.2.4 Pfizer Adult Vaccines Product Portfolio

      • 11.2.5 Recent Research and Development Strategies

    • 11.3 Protein Sciences

      • 11.3.1 Protein Sciences Company Details

      • 11.3.2 Protein Sciences Adult Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 11.3.3 Protein Sciences Adult Vaccines Main Business and Markets Served

      • 11.3.4 Protein Sciences Adult Vaccines Product Portfolio

      • 11.3.5 Recent Research and Development Strategies

    • 11.4 Sanofi Pasteur

      • 11.4.1 Sanofi Pasteur Company Details

      • 11.4.2 Sanofi Pasteur Adult Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 11.4.3 Sanofi Pasteur Adult Vaccines Main Business and Markets Served

      • 11.4.4 Sanofi Pasteur Adult Vaccines Product Portfolio

      • 11.4.5 Recent Research and Development Strategies

    • 11.5 Merck

      • 11.5.1 Merck Company Details

      • 11.5.2 Merck Adult Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 11.5.3 Merck Adult Vaccines Main Business and Markets Served

      • 11.5.4 Merck Adult Vaccines Product Portfolio

      • 11.5.5 Recent Research and Development Strategies

    • 11.6 GlaxoSmithKline

      • 11.6.1 GlaxoSmithKline Company Details

      • 11.6.2 GlaxoSmithKline Adult Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 11.6.3 GlaxoSmithKline Adult Vaccines Main Business and Markets Served

      • 11.6.4 GlaxoSmithKline Adult Vaccines Product Portfolio

      • 11.6.5 Recent Research and Development Strategies

    • 11.7 BioCSL (Seqirus)

      • 11.7.1 BioCSL (Seqirus) Company Details

      • 11.7.2 BioCSL (Seqirus) Adult Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 11.7.3 BioCSL (Seqirus) Adult Vaccines Main Business and Markets Served

      • 11.7.4 BioCSL (Seqirus) Adult Vaccines Product Portfolio

      • 11.7.5 Recent Research and Development Strategies

    12 Global Adult Vaccines Market Outlook by Types and Applications to 2028

    • 12.1 Global Adult Vaccines Consumption Forecast and Growth Rate by Type (2022-2028)

      • 12.1.1 Global Influenza Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.2 Global Cervical Cancer Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.3 Global Zoster Shingles Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.4 Global Pneumococcal Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.5 Global Meningococcal Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.6 Global MMRV Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.7 Global Hepatitis Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.8 Global DTP Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.9 Global Travel and Miscellaneous Consumption Forecast and Growth Rate (2022-2028)

    • 12.2 Global Adult Vaccines Consumption Forecast and Growth Rate by Application (2022-2028)

      • 12.2.1 Global Medical Care Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.2 Global Healthy Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.3 Global Hospita Consumption Forecast and Growth Rate (2022-2028)

    13 Country-wise Adult Vaccines Market Analysis and Outlook to 2028

    • 13.1 Global Adult Vaccines Consumption Forecast (2022-2028)

    • 13.2 North America Consumption Analysis

      • 13.2.1 United States Adult Vaccines Consumption Forecast (2022-2028)

      • 13.2.2 Canada Adult Vaccines Consumption Forecast (2022-2028)

      • 13.2.3 Mexico Adult Vaccines Consumption Forecast (2022-2028)

    • 13.3 Europe Consumption Analysis

      • 13.3.1 Germany Adult Vaccines Consumption Forecast (2022-2028)

      • 13.3.2 UK Adult Vaccines Consumption Forecast (2022-2028)

      • 13.3.3 Spain Adult Vaccines Consumption Forecast (2022-2028)

      • 13.3.4 Belgium Adult Vaccines Consumption Forecast (2022-2028)

      • 13.3.5 France Adult Vaccines Consumption Forecast (2022-2028)

      • 13.3.6 Italy Adult Vaccines Consumption Forecast (2022-2028)

      • 13.3.7 Denmark Adult Vaccines Consumption Forecast (2022-2028)

      • 13.3.8 Finland Adult Vaccines Consumption Forecast (2022-2028)

      • 13.3.9 Norway Adult Vaccines Consumption Forecast (2022-2028)

      • 13.3.10 Sweden Adult Vaccines Consumption Forecast (2022-2028)

      • 13.3.11 Poland Adult Vaccines Consumption Forecast (2022-2028)

      • 13.3.12 Russia Adult Vaccines Consumption Forecast (2022-2028)

      • 13.3.13 Turkey Adult Vaccines Consumption Forecast (2022-2028)

    • 13.4 APAC Consumption Analysis

      • 13.4.1 China Adult Vaccines Consumption Forecast (2022-2028)

      • 13.4.2 Japan Adult Vaccines Consumption Forecast (2022-2028)

      • 13.4.3 India Adult Vaccines Consumption Forecast (2022-2028)

      • 13.4.4 South Korea Adult Vaccines Consumption Forecast (2022-2028)

      • 13.4.5 Pakistan Adult Vaccines Consumption Forecast (2022-2028)

      • 13.4.6 Bangladesh Adult Vaccines Consumption Forecast (2022-2028)

      • 13.4.7 Indonesia Adult Vaccines Consumption Forecast (2022-2028)

      • 13.4.8 Thailand Adult Vaccines Consumption Forecast (2022-2028)

      • 13.4.9 Singapore Adult Vaccines Consumption Forecast (2022-2028)

      • 13.4.10 Malaysia Adult Vaccines Consumption Forecast (2022-2028)

      • 13.4.11 Philippines Adult Vaccines Consumption Forecast (2022-2028)

      • 13.4.12 Vietnam Adult Vaccines Consumption Forecast (2022-2028)

    • 13.5 South America Consumption Analysis

      • 13.5.1 Brazil Adult Vaccines Consumption Forecast (2022-2028)

      • 13.5.2 Colombia Adult Vaccines Consumption Forecast (2022-2028)

      • 13.5.3 Chile Adult Vaccines Consumption Forecast (2022-2028)

      • 13.5.4 Argentina Adult Vaccines Consumption Forecast (2022-2028)

      • 13.5.5 Venezuela Adult Vaccines Consumption Forecast (2022-2028)

      • 13.5.6 Peru Adult Vaccines Consumption Forecast (2022-2028)

      • 13.5.7 Puerto Rico Adult Vaccines Consumption Forecast (2022-2028)

      • 13.5.8 Ecuador Adult Vaccines Consumption Forecast (2022-2028)

    • 13.6 GCC Consumption Analysis

      • 13.6.1 Bahrain Adult Vaccines Consumption Forecast (2022-2028)

      • 13.6.2 Kuwait Adult Vaccines Consumption Forecast (2022-2028)

      • 13.6.3 Oman Adult Vaccines Consumption Forecast (2022-2028)

      • 13.6.4 Qatar Adult Vaccines Consumption Forecast (2022-2028)

      • 13.6.5 Saudi Arabia Adult Vaccines Consumption Forecast (2022-2028)

      • 13.6.6 United Arab Emirates Adult Vaccines Consumption Forecast (2022-2028)

    • 13.7 Africa Consumption Analysis

      • 13.7.1 Nigeria Adult Vaccines Consumption Forecast (2022-2028)

      • 13.7.2 South Africa Adult Vaccines Consumption Forecast (2022-2028)

      • 13.7.3 Egypt Adult Vaccines Consumption Forecast (2022-2028)

      • 13.7.4 Algeria Adult Vaccines Consumption Forecast (2022-2028)

    • 13.8 Oceania Consumption Analysis

      • 13.8.1 Australia Adult Vaccines Consumption Forecast (2022-2028)

      • 13.8.2 New Zealand Adult Vaccines Consumption Forecast (2022-2028)

    14 Conclusions


    The List of Tables and Figures

    • Table Definition of Adult Vaccines

    • Figure of Adult Vaccines Picture

    • Table Global Adult Vaccines Import by Region (Top 10 Countries) (2017-2028)

    • Table Global Adult Vaccines Export by Region (Top 10 Countries) (2017-2028)

    • Figure Global Influenza Consumption and Growth Rate (2017-2022)

    • Figure Global Cervical Cancer Consumption and Growth Rate (2017-2022)

    • Figure Global Zoster Shingles Consumption and Growth Rate (2017-2022)

    • Figure Global Pneumococcal Consumption and Growth Rate (2017-2022)

    • Figure Global Meningococcal Consumption and Growth Rate (2017-2022)

    • Figure Global MMRV Consumption and Growth Rate (2017-2022)

    • Figure Global Hepatitis Consumption and Growth Rate (2017-2022)

    • Figure Global DTP Consumption and Growth Rate (2017-2022)

    • Figure Global Travel and Miscellaneous Consumption and Growth Rate (2017-2022)

    • Figure Global Medical Care Consumption and Growth Rate (2017-2022)

    • Figure Global Healthy Consumption and Growth Rate (2017-2022)

    • Figure Global Hospita Consumption and Growth Rate (2017-2022)

    • Figure Global Adult Vaccines Consumption by Country (2017-2022)

    • Table North America Adult Vaccines Consumption by Country (2017-2022)

    • Figure United States Adult Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Canada Adult Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Mexico Adult Vaccines Consumption and Growth Rate (2017-2022)

    • Table Europe Adult Vaccines Consumption by Country (2017-2022)

    • Figure Germany Adult Vaccines Consumption and Growth Rate (2017-2022)

    • Figure UK Adult Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Spain Adult Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Belgium Adult Vaccines Consumption and Growth Rate (2017-2022)

    • Figure France Adult Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Italy Adult Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Denmark Adult Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Finland Adult Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Norway Adult Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Sweden Adult Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Poland Adult Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Russia Adult Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Turkey Adult Vaccines Consumption and Growth Rate (2017-2022)

    • Table APAC Adult Vaccines Consumption by Country (2017-2022)

    • Figure China Adult Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Japan Adult Vaccines Consumption and Growth Rate (2017-2022)

    • Figure India Adult Vaccines Consumption and Growth Rate (2017-2022)

    • Figure South Korea Adult Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Pakistan Adult Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Bangladesh Adult Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Indonesia Adult Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Thailand Adult Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Singapore Adult Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Malaysia Adult Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Philippines Adult Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Vietnam Adult Vaccines Consumption and Growth Rate (2017-2022)

    • Table South America Adult Vaccines Consumption by Country (2017-2022)

    • Figure Brazil Adult Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Colombia Adult Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Chile Adult Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Argentina Adult Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Venezuela Adult Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Peru Adult Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Puerto Rico Adult Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Ecuador Adult Vaccines Consumption and Growth Rate (2017-2022)

    • Table GCC Adult Vaccines Consumption by Country (2017-2022)

    • Figure Bahrain Adult Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Kuwait Adult Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Oman Adult Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Qatar Adult Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Saudi Arabia Adult Vaccines Consumption and Growth Rate (2017-2022)

    • Figure United Arab Emirates Adult Vaccines Consumption and Growth Rate (2017-2022)

    • Table Africa Adult Vaccines Consumption by Country (2017-2022)

    • Figure Nigeria Adult Vaccines Consumption and Growth Rate (2017-2022)

    • Figure South Africa Adult Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Egypt Adult Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Algeria Adult Vaccines Consumption and Growth Rate (2017-2022)

    • Table Oceania Adult Vaccines Consumption by Country (2017-2022)

    • Figure Australia Adult Vaccines Consumption and Growth Rate (2017-2022)

    • Figure New Zealand Adult Vaccines Consumption and Growth Rate (2017-2022)

    • Table Novartis Company Details

    • Table Novartis Adult Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis Adult Vaccines Main Business and Markets Served

    • Table Novartis Adult Vaccines Product Portfolio

    • Table Pfizer Company Details

    • Table Pfizer Adult Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer Adult Vaccines Main Business and Markets Served

    • Table Pfizer Adult Vaccines Product Portfolio

    • Table Protein Sciences Company Details

    • Table Protein Sciences Adult Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Protein Sciences Adult Vaccines Main Business and Markets Served

    • Table Protein Sciences Adult Vaccines Product Portfolio

    • Table Sanofi Pasteur Company Details

    • Table Sanofi Pasteur Adult Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sanofi Pasteur Adult Vaccines Main Business and Markets Served

    • Table Sanofi Pasteur Adult Vaccines Product Portfolio

    • Table Merck Company Details

    • Table Merck Adult Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merck Adult Vaccines Main Business and Markets Served

    • Table Merck Adult Vaccines Product Portfolio

    • Table GlaxoSmithKline Company Details

    • Table GlaxoSmithKline Adult Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table GlaxoSmithKline Adult Vaccines Main Business and Markets Served

    • Table GlaxoSmithKline Adult Vaccines Product Portfolio

    • Table BioCSL (Seqirus) Company Details

    • Table BioCSL (Seqirus) Adult Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table BioCSL (Seqirus) Adult Vaccines Main Business and Markets Served

    • Table BioCSL (Seqirus) Adult Vaccines Product Portfolio

    • Figure Global Influenza Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Cervical Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Zoster Shingles Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Pneumococcal Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Meningococcal Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global MMRV Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hepatitis Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global DTP Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Travel and Miscellaneous Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Medical Care Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Healthy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospita Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Adult Vaccines Consumption Forecast by Country (2022-2028)

    • Table North America Adult Vaccines Consumption Forecast by Country (2022-2028)

    • Figure United States Adult Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Canada Adult Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Mexico Adult Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Adult Vaccines Consumption Forecast by Country (2022-2028)

    • Figure Germany Adult Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure UK Adult Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Spain Adult Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Belgium Adult Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure France Adult Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Italy Adult Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Denmark Adult Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Finland Adult Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Norway Adult Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Sweden Adult Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Poland Adult Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Russia Adult Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Turkey Adult Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Table APAC Adult Vaccines Consumption Forecast by Country (2022-2028)

    • Figure China Adult Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Adult Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Adult Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Adult Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Pakistan Adult Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Bangladesh Adult Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Indonesia Adult Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Thailand Adult Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Singapore Adult Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Malaysia Adult Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Philippines Adult Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Vietnam Adult Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Table South America Adult Vaccines Consumption Forecast by Country (2022-2028)

    • Figure Brazil Adult Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Colombia Adult Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Chile Adult Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Argentina Adult Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Venezuela Adult Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Peru Adult Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Puerto Rico Adult Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Ecuador Adult Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Table GCC Adult Vaccines Consumption Forecast by Country (2022-2028)

    • Figure Bahrain Adult Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Kuwait Adult Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Oman Adult Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Qatar Adult Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Saudi Arabia Adult Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure United Arab Emirates Adult Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Table Africa Adult Vaccines Consumption Forecast by Country (2022-2028)

    • Figure Nigeria Adult Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Africa Adult Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Egypt Adult Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Algeria Adult Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Table Oceania Adult Vaccines Consumption Forecast by Country (2022-2028)

    • Figure Australia Adult Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure New Zealand Adult Vaccines Consumption Forecast and Growth Rate (2022-2028)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US